Barry B. Bercu, MD
Dr. Bercu joined the USF faculty in 1984 after seven years at the National Institute of Child Health and Human Development at the NIH in Bethesda, Maryland. At the NIH, he established the pediatric endocrine training program while conducting novel basic and clinical research in his laboratory. Dr. Bercu is recognized for his scientific work in the areas of neuroregulation of growth, hormone secretion, sexual development and generalized resistance to thyroid hormone. He described a novel clinical entity entitled Growth Hormone Neurosecretory Dysfunction (GHND). Dr. Bercu also characterized the clinical and molecular abnormalities in a unique child with generalized resistance to thyroid hormone. The Bercu Patient is noted in the related scientific literature because of the autosomal double dominant inheritance and description of the extensive S kindred.
Education & Training
| B.S. | University of Maryland; Zoology, 1965 |
| M.D. | University of Maryland, 1969 |
| Internal Medicine Internship | V and VI Medical Service, Boston City Hospital, Boston University School of Medicine, 1970 |
| Pediatric Residency | Mass. General Hospital, Harvard Medical School, 1972 |
| Fellowship |
Pediatric Endocrinology, Massachusetts General Hospital, Harvard Medical School, 1977 Endocrinology, Department of Internal Medicine, New England Medical Center, Tufts University Medical School, 1977 |
Board Certifications
- American Board of Pediatrics
- Pediatric Endocrinology
Scholarly Activity
Dr. Bercu is an author of over 180 articles in scholarly journals and book chapters and has edited seven books. He has served as a guest editor for several journal publications. Dr. Bercu has served on the editorial boards of several prominent international scientific journals and functioned as a scientific reviewer for over 25 journals. Dr. Bercu was appointed as a member of the Endocrinologic and Metabolic Advisory Panel of the FDA where he served an extended term. He has been selected to serve on various NIH panels, including site reviews. Dr. Bercu has received grant funding from multiple sources, including government, foundations and pharmaceutical companies. He is the holder of seven patents in the medical field. Dr. Bercu has lectured both nationally and internationally in his area of scientific expertise and on bioethical/IRB issues. He has organized over 30 international/national symposia in scientific areas including growth hormone, growth hormone secretagogues, aging, pituitary disease, integrative medicine and in the field of bioethics. The latter combines Dr. Bercu’s symposium expertise and his tenure as chair of the USF Biomedical Institutional Review Board. Dr. Bercu is chair of the Dean’s Lecture Series. As a clinician, Dr. Bercu has been recognized annually in the national edition of The Best Doctors in America. Dr. Bercu has mentored junior clinical researchers and fellows from the United States and abroad. He was honored in 1998 for his academic accomplishments and service to the University with the PEP (Professional Excellence Program) Award. Dr. Bercu is a member of numerous professional societies including the prestigious Society for Pediatric Research and the American Pediatric Society.
